AXOVANT SCIENCES LTD's ticker is AXGTXXXX and the CUSIP is G0750W104. A total of 2 filers reported holding AXOVANT SCIENCES LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 150 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -75.0% | 150 | -76.9% | 0.00% | – |
| Q3 2017 | $4,000 | -71.4% | 650 | +8.3% | 0.00% | -100.0% |
| Q2 2017 | $14,000 | +40.0% | 600 | -14.3% | 0.00% | – |
| Q1 2017 | $10,000 | +11.1% | 700 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | +200.0% | 700 | +250.0% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | – |
| Q4 2015 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 75,000,000 | $969,000,000 | 33.20% |
| RA Capital Management | 5,000,000 | $64,600,000 | 9.28% |
| Avoro Capital Advisors LLC | 406,470 | $5,252,000 | 1.36% |
| ACUTA CAPITAL PARTNERS, LLC | 140,000 | $1,809,000 | 1.05% |
| Visium Asset Management, LP | 5,159,160 | $66,656,000 | 0.91% |
| DELTEC ASSET MANAGEMENT LLC | 162,417 | $2,098,000 | 0.52% |
| Atika Capital Management LLC | 75,000 | $969,000 | 0.48% |
| Perceptive Advisors | 820,000 | $10,594,000 | 0.42% |
| Vident Investment Advisory, LLC | 167,551 | $2,165,000 | 0.30% |
| Foresite Capital Management II, LLC | 65,000 | $840,000 | 0.26% |